Finance

Lists
NANO:EPA
Nanobiotix SA
19,74 €
+0,92%
(+0,18) 1D
15-окт., 17:35:18 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NANO...
Open
19,08 €
High
20,00 €
Low
19,00 €
Mkt. cap
1,00 млд
Avg. vol.
164,27 миң
Volume
107,42 миң
52-wk high
47,66 €
52-wk low
13,10 €
EPS
-1,09 €
Shares outstanding
50,83 млн
No. of employees
98
Open
19,08 €
High
20,00 €
Low
19,00 €
Mkt. cap
1,00 млд
Avg. vol.
164,27 миң
Volume
107,42 миң
52-wk high
47,66 €
52-wk low
13,10 €
EPS
-1,09 €
Shares outstanding
50,83 млн
No. of employees
98
News stories
From web sources and news partners
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA
CEOLaurent Levy
Employees98
Founded2003
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,98 млн
2,98 млн
2,78 млн
2,78 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,29 млн
4,29 млн
6,36 млн
6,36 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,53 млн
4,53 млн
5,38 млн
5,38 млн
Operating expense
8,83 млн
8,83 млн
11,74 млн
11,74 млн
Total operating expenses
8,83 млн
8,83 млн
11,74 млн
11,74 млн
Operating income
-5,85 млн
-5,85 млн
-8,96 млн
-8,96 млн
Other non operating income
-8,50 миң
-8,50 миң
-1,00 миң
-1,00 миң
EBT including unusual items
-9,29 млн
-9,29 млн
-17,14 млн
-17,14 млн
EBT excluding unusual items
-8,57 млн
-8,57 млн
-16,56 млн
-16,56 млн
Income tax expense
-1,50 миң
-1,50 миң
8,00 миң
8,00 миң
Effective tax rate
0,02%
0,02%
-0,05%
-0,05%
Other operating expenses
-
-
-
-
Net income
-9,29 млн
-9,29 млн
-17,14 млн
-17,14 млн
Net profit margin
-311,97%
-311,97%
-617,69%
-617,69%
Earnings per share
-
-
-
-
Interest and investment income
193,50 миң
193,50 миң
338,50 миң
338,50 миң
Interest expense
-3,08 млн
-3,08 млн
-7,28 млн
-7,28 млн
Net interest expenses
-2,88 млн
-2,88 млн
-6,94 млн
-6,94 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,79 млн
-5,79 млн
-8,84 млн
-8,84 млн
Gain or loss from assets sale
76,50 миң
76,50 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору